Chemoinformaics analysis of 2,5-dihydroxy-7-methoxyflavanone
Molecular Weight | 286.283 | nRot | 2 |
Heavy Atom Molecular Weight | 272.171 | nRig | 18 |
Exact Molecular Weight | 286.084 | nRing | 3 |
Solubility: LogS | -3.765 | nHRing | 1 |
Solubility: LogP | 2.526 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
nHA | 5 | APOL | 40.0651 |
nHD | 2 | BPOL | 18.3849 |
QED | 0.885 |
Synth | 2.962 |
Natural Product Likeliness | 1.41 |
NR-PPAR-gamma | 0.453 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.008 |
Pgp-sub | 0.001 |
HIA | 0.014 |
CACO-2 | -4.769 |
MDCK | 0.0000211 |
BBB | 0.445 |
PPB | 0.923542 |
VDSS | 0.933 |
FU | 0.038095 |
CYP1A2-inh | 0.853 |
CYP1A2-sub | 0.558 |
CYP2c19-inh | 0.606 |
CYP2c19-sub | 0.495 |
CYP2c9-inh | 0.612 |
CYP2c9-sub | 0.893 |
CYP2d6-inh | 0.595 |
CYP2d6-sub | 0.726 |
CYP3a4-inh | 0.518 |
CYP3a4-sub | 0.384 |
CL | 11.143 |
T12 | 0.336 |
hERG | 0.028 |
Ames | 0.077 |
ROA | 0.087 |
SkinSen | 0.451 |
Carcinogencity | 0.297 |
EI | 0.327 |
Respiratory | 0.419 |
NR-Aromatase | 0.672 |
Antiviral | Yes |
Prediction | 0.88162 |